Skip to main content

Advertisement

Open Peer Review Reports for: Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
12 Apr 2017 Submitted Original manuscript
7 May 2017 Reviewed Reviewer Report - Alessandro Morabito
8 May 2017 Reviewed Reviewer Report - Koji Takeda
24 May 2017 Reviewed Reviewer Report - M. Hassan Murad
21 Jul 2017 Author responded Author comments - Perrine Créquit
Resubmission - Version 2
21 Jul 2017 Submitted Manuscript version 2
2 Aug 2017 Reviewed Reviewer Report - Koji Takeda
11 Aug 2017 Reviewed Reviewer Report - M. Hassan Murad
24 Aug 2017 Author responded Author comments - Perrine Créquit
Resubmission - Version 3
24 Aug 2017 Submitted Manuscript version 3
1 Sep 2017 Reviewed Reviewer Report - M. Hassan Murad
8 Sep 2017 Author responded Author comments - Perrine Créquit
Resubmission - Version 4
8 Sep 2017 Submitted Manuscript version 4
27 Sep 2017 Author responded Author comments - Perrine Créquit
Resubmission - Version 5
27 Sep 2017 Submitted Manuscript version 5
Publishing
9 Oct 2017 Editorially accepted
30 Oct 2017 Article published 10.1186/s12916-017-0954-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement